1 |
CH0113817123 |
Bellevue Biotech DT CHF |
+4,67 % |
+18,17 % |
0,12 |
2 |
LU1269736838 |
Candriam Equities L Biotech.R EUR Acc |
+2,75 % |
+18,06 % |
0,01 |
3 |
LU1120766032 |
Candriam Equities L Biotech.I EUR Acc |
+2,56 % |
+17,81 % |
0,00 |
4 |
LU2026682919 |
Candriam Equities L Biotech.V2 USD Acc |
+2,16 % |
+17,71 % |
-0,02 |
5 |
LU0942225912 |
Candriam Equities L Biotech.R USD Acc |
+1,93 % |
+17,69 % |
-0,03 |
|
23 |
LU1769088235 |
UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse (EUR) Q-acc, EUR |
-1,24 % |
+19,02 % |
-0,20 |
|
73 |
LU0774687577 |
Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse Z (acc) GBP |
-10,03 % |
+17,82 % |
-0,70 |
74 |
LU1803069274 |
F.Biotechnology Dis.Fd.A-H1 EUR H |
-11,03 % |
+18,93 % |
-0,72 |
75 |
LU0959058974 |
Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse A (acc) CHF-H1 |
-13,38 % |
+18,99 % |
-0,84 |
76 |
DE000A3DCA95 |
BIT Biotech Opportunities S |
-30,52 % |
+29,53 % |
-1,12 |
77 |
DE000A3DCBA0 |
BIT Biotech Opportunities I-II |
-30,71 % |
+29,52 % |
-1,13 |